SEARCH RESULTS FOR: "Tag: AMRN"
REFINE YOUR SEARCH:
RECENT
Last Month(2)
ARTICLES/BLOGS
2019(7)
2018(6)
2015(3)
CATEGORIES
Analyst Update(1)
Buzz Stocks(4)
General(3)
Midday Market Check(1)
Opening View(1)
Quantitative Analysis(2)
Stocks On the Move(4)
Technical Analysis(1)

7/2/2019 9:37 AM
Amarin Corporation plc (NASDAQ:AMRN) stock is trading up 6.8% at $20.55 this morning, after the cardiovascular disease specialist said it expects 2019 revenue to arrive between $380 million and $420 m...
7/2/2019 9:21 AM
The U.S. Trade Representative's (USTR) office last night released details of a proposal to tack on $4 billion in tariffs on a number of European Union (EU) goods, which has Dow futures cooling off t...
5/29/2019 9:31 AM
Shares of the pharmaceutical concern Amarin Corporation plc (NASDAQ:AMRN) are popping, after the Food and Drug Administration (FDA) granted priority review to the drugmaker's Vascepa treatment, whi...
3/28/2019 10:08 AM
Amarin Corporation (NASDAQ:AMRN) stock is up 4.5%% to trade at $18.75, after the American Diabetes Association (ADA) recommended Vascepa, Amarin's fish oil-based triglyceride treatment, for patients w...
3/20/2019 2:51 PM
Pharmaceutical concerns Sarepta Therapeutics Inc (NASDAQ:SRPT) and Amarin Corporation (NASDAQ:AMRN) have recently retreated from new highs. However, both stocks are approaching key levels that could ...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center